Inventor · disambiguated record
Yiqing Feng
Also filed as: FENG YIQING
20 granted patents·14 pending applications·230 citations·filing 1997–2024
95Inventor score
Top patents by PatentIndex Score
34 records- 0191US9522957B2Method of treating an inflammatory condition by administering toll-like 3 receptor antagonistsJANSSEN BIOTECH INC·Filed 2013·Granted Dec 20, 2016·10 cites·7 claims
- 0290US9481731B2Toll-like receptor 3 antagonistsJANSSEN BIOTECH INC·Filed 2013·Granted Nov 1, 2016·9 cites·10 claims
- 0390US9255153B2Polynucleotides encoding Toll-Like Receptor 3 antagonistsCUNNINGHAM MARK·Filed 2013·Granted Feb 9, 2016·10 cites·9 claims
- 0487US8399630B2Engineered anti-IL-13 antibodies, compositions, methods and usesSWANSON RONALD V·Filed 2009·Granted Mar 19, 2013·11 cites·5 claims
- 0586US10493148B2PD-1 agonist antibodies and uses thereofLILLY CO ELI·Filed 2019·Granted Dec 3, 2019·11 cites·12 claims
- 0685US6730303B1Fused G-CSF and IL-3 proteins and uses thereofPHARMACIA CORP·Filed 2000·Granted May 4, 2004·12 cites·27 claims
- 0782US9493489B2Boron-containing small molecules as anti-protozoal agentsJACOBS ROBERT·Filed 2009·Granted Nov 15, 2016·11 cites·57 claims
- 0882US9238693B2Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodiesCUNNINGHAM MARK·Filed 2013·Granted Jan 19, 2016·3 cites·9 claims
- 0980US8409567B2Toll-like receptor 3 antagonistsCUNNINGHAM MARK·Filed 2009·Granted Apr 2, 2013·2 cites·17 claims
- 1080US5969105AStem cell factor receptor agonistsFiled 1997·Granted Oct 19, 1999·52 cites·12 claims
- 1178US9932404B2Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonistJANSSEN BIOTECH INC·Filed 2016·Granted Apr 3, 2018·1 cites·18 claims
- 1278US8540986B2Toll-like receptor 3 antagonistsCUNNINGHAM MARK·Filed 2010·Granted Sep 24, 2013·2 cites·9 claims
- 1373US8460659B2Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseasesCUNNINGHAM MARK·Filed 2011·Granted Jun 11, 2013·2 cites·5 claims
- 1473US6066318AMulti-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factorsSEARLE & CO·Filed 1997·Granted May 23, 2000·22 cites·58 claims
- 1573US2024398973A1Engineered antibody compounds and conjugates thereofLILLY CO ELI·Filed 2024·Application pending·0 cites
- 1672US6660257B1Circular permuteins of flt3 ligandPHARMACIA CORP·Filed 1997·Granted Dec 9, 2003·26 cites·11 claims
- 1770US6100070AG-CSF receptor agonistsSEARLE & CO·Filed 1997·Granted Aug 8, 2000·35 cites·21 claims
- 1866US2018179294A1Toll-like receptor 3 antagonistsJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 1961US2004171115A1Multi-functional hematopoietic fusion proteins between sequence rearranged G-CSF receptor agonists and other hematopoietic factorsFiled 2003·Application pending·0 cites
- 2058US2023192837A1Human tumor necrosis factor alpha antibodiesLILLY CO ELI·Filed 2022·Application pending·0 cites
- 2157US2024082414A1Human tumor necrosis factor alpha antibody glucocorticoid conjugatesLILLY CO ELI·Filed 2023·Application pending·0 cites
- 2256US2024100176A1Human interleukin-4 receptor alpha antibody glucocorticoid conjugatesLILLY CO ELI·Filed 2023·Application pending·0 cites
- 2356US2020155702A1Engineered Antibody Compounds and Conjuates ThereofLILLY CO ELI·Filed 2018·Application pending·0 cites
- 2454US11891441B2Human interleukin-4 receptor alpha antibodiesLILLY CO ELI·Filed 2022·Granted Feb 6, 2024·0 cites·69 claims
- 2554US11167039B2MET antibody drug conjugatesLILLY CO ELI·Filed 2017·Granted Nov 9, 2021·0 cites·13 claims
- 2654US2004127410A1Circular permuteins of flt3 ligandFiled 2003·Application pending·0 cites
- 2752US6967092B1Multi-functional chimeric hematopoietic receptor agonistsMC KEARN JOHN P·Filed 1997·Granted Nov 22, 2005·11 cites·37 claims
- 2849US11939381B2Bispecific antibodies targeting immune checkpointsLILLY CO ELI·Filed 2019·Granted Mar 26, 2024·0 cites·20 claims
- 2949US2014017250A1Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular DiseasesCUNNINGHAM MARK·Filed 2013·Application pending·0 cites
- 3046US2022227860A1Tigit and pd-1/tigit-binding moleculesLILLY CO ELI·Filed 2020·Application pending·0 cites
- 3146US2006172932A1Novel erythropoietin receptor agonistsSUMMERS NEENA L·Filed 2004·Application pending·0 cites
- 3241US2007081979A1Multi-functional chimeric hematopoietic receptor agonistsMC KEARN JOHN P·Filed 2005·Application pending·0 cites
- 3341US2013090457A1Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular DiseasesCUNNINGHAM MARK·Filed 2012·Application pending·0 cites
- 3441US2019270778A1Cyclic Peptides As C5a Receptor AntagonistsPFIZER·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yiqing Feng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →